HomeCONGRESS

CONGRESS

ACC 2022 | VALOR-HCM: Mavacamten in Adults with Symptomatic Obstructive HCM Eligible for Septal Reduction Therapy

Roughly 50% of hypertrophic cardiomyopathies (HCM) are obstructive, and of this percentage, most of symptoms can be...

ACC 2022 – POISE-3: Tranexamic Acid, Bleeding and Cardiovascular Events in Non-Cardiac Surgeries

Tranexamic Acid is an antifibrinolytic which has been shown to reduce bleeding in orthopedic patients and cardiac...

ACC 2022

Here are the most important scientific articles of the ACC 2022 Congress. If you cannot view the articles,...

Rewatch our Webinar on Conquering Complex Coronary Lesions on our Youtube channel

Rewatch our Webinar on Conquering Complex Coronary Lesions on our Youtube channel. See it below! Conquering Complex Coronary Lesions

SOLACI’s Symposium at PCI Global Summit

More SOLACI activities before the end of the year! We invite you to join this scientific activity of...

SOLACI Symposium at Heart Failure and Pulmonary Hypertension – VI International Summit 2021

We invite you to take part in SOLACI’s Symposium at the Heart Failure and Pulmonary Hypertension –...

AHA 2021 | Meta-Analysis of Surgery vs. Angioplasty in Left Main Coronary Artery Disease

According to this new meta-analysis (presented at AHA 2021 and published in The Lancet), mortality is similar between...

AHA 2021 | CRAVE: Coffee Safety in Rhythm Disorders

On the one side, caffeine can increase arrythmias or interfere with sleeping, but on the other hand,...